Skip to main content

Site notifications

Notice for sepiapterin (PTC THERAPEUTICS AUSTRALIA PTY LIMITED)

Active ingredients
sepiapterin
Date of review outcome
Lapse date
Type
Orphan drug
Dosage form(s)
Oral Powder
Indication
Treatment of hyperphenylalaninaemia
Therapeutic area
Inherited metabolic disorders

Help us improve the Therapeutic Goods Administration site